Are data from different gene expression microarray platforms comparable?

Anna-Kaarina Järvinen, Sampsa Hautaniemi, Henrik Edgren, Petri Auvinen, Janna Saarela, Olli Kallioniemi, Outi Monni (Corresponding Author)

Research output: Contribution to journalArticleScientificpeer-review

150 Citations (Scopus)

Abstract

Many commercial and custom-made microarray formats are routinely used for large-scale gene expression surveys. Here, we sought to determine the level of concordance between microarray platforms by analyzing breast cancer cell lines with in situ synthesized oligonucleotide arrays (Affymetrix HG-U95v2), commercial cDNA microarrays (Agilent Human 1 cDNA), and custom-made cDNA microarrays from a sequence-validated 13K cDNA library. Gene expression data from the commercial platforms showed good correlations across the experiments (r = 0.78–0.86), whereas the correlations between the custom-made and either of the two commercial platforms were lower (r = 0.62–0.76). Discrepant findings were due to clone errors on the custom-made microarrays, old annotations, or unknown causes. Even within platform, there can be several ways to analyze data that may influence the correlation between platforms. Our results indicate that combining data from different microarray platforms is not straightforward. Variability of the data represents a challenge for developing future diagnostic applications of microarrays.
Original languageEnglish
Pages (from-to)1164 - 1168
Number of pages5
JournalGenomics
Volume83
Issue number6
DOIs
Publication statusPublished - 2004
MoE publication typeA1 Journal article-refereed

Fingerprint

Oligonucleotide Array Sequence Analysis
Gene Expression
Gene Library
Complementary DNA
Clone Cells
Breast Neoplasms
Cell Line

Keywords

  • cDNA microarrays
  • Oligonucleotide microarrays
  • Quality control
  • Breast cancer

Cite this

Järvinen, A-K., Hautaniemi, S., Edgren, H., Auvinen, P., Saarela, J., Kallioniemi, O., & Monni, O. (2004). Are data from different gene expression microarray platforms comparable? Genomics, 83(6), 1164 - 1168. https://doi.org/10.1016/j.ygeno.2004.01.004
Järvinen, Anna-Kaarina ; Hautaniemi, Sampsa ; Edgren, Henrik ; Auvinen, Petri ; Saarela, Janna ; Kallioniemi, Olli ; Monni, Outi. / Are data from different gene expression microarray platforms comparable?. In: Genomics. 2004 ; Vol. 83, No. 6. pp. 1164 - 1168.
@article{9f9d1218c2844c5db11e323f9e3b0421,
title = "Are data from different gene expression microarray platforms comparable?",
abstract = "Many commercial and custom-made microarray formats are routinely used for large-scale gene expression surveys. Here, we sought to determine the level of concordance between microarray platforms by analyzing breast cancer cell lines with in situ synthesized oligonucleotide arrays (Affymetrix HG-U95v2), commercial cDNA microarrays (Agilent Human 1 cDNA), and custom-made cDNA microarrays from a sequence-validated 13K cDNA library. Gene expression data from the commercial platforms showed good correlations across the experiments (r = 0.78–0.86), whereas the correlations between the custom-made and either of the two commercial platforms were lower (r = 0.62–0.76). Discrepant findings were due to clone errors on the custom-made microarrays, old annotations, or unknown causes. Even within platform, there can be several ways to analyze data that may influence the correlation between platforms. Our results indicate that combining data from different microarray platforms is not straightforward. Variability of the data represents a challenge for developing future diagnostic applications of microarrays.",
keywords = "cDNA microarrays, Oligonucleotide microarrays, Quality control, Breast cancer",
author = "Anna-Kaarina J{\"a}rvinen and Sampsa Hautaniemi and Henrik Edgren and Petri Auvinen and Janna Saarela and Olli Kallioniemi and Outi Monni",
year = "2004",
doi = "10.1016/j.ygeno.2004.01.004",
language = "English",
volume = "83",
pages = "1164 -- 1168",
journal = "Genomics",
issn = "0888-7543",
publisher = "Academic Press",
number = "6",

}

Järvinen, A-K, Hautaniemi, S, Edgren, H, Auvinen, P, Saarela, J, Kallioniemi, O & Monni, O 2004, 'Are data from different gene expression microarray platforms comparable?', Genomics, vol. 83, no. 6, pp. 1164 - 1168. https://doi.org/10.1016/j.ygeno.2004.01.004

Are data from different gene expression microarray platforms comparable? / Järvinen, Anna-Kaarina; Hautaniemi, Sampsa; Edgren, Henrik; Auvinen, Petri; Saarela, Janna; Kallioniemi, Olli; Monni, Outi (Corresponding Author).

In: Genomics, Vol. 83, No. 6, 2004, p. 1164 - 1168.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Are data from different gene expression microarray platforms comparable?

AU - Järvinen, Anna-Kaarina

AU - Hautaniemi, Sampsa

AU - Edgren, Henrik

AU - Auvinen, Petri

AU - Saarela, Janna

AU - Kallioniemi, Olli

AU - Monni, Outi

PY - 2004

Y1 - 2004

N2 - Many commercial and custom-made microarray formats are routinely used for large-scale gene expression surveys. Here, we sought to determine the level of concordance between microarray platforms by analyzing breast cancer cell lines with in situ synthesized oligonucleotide arrays (Affymetrix HG-U95v2), commercial cDNA microarrays (Agilent Human 1 cDNA), and custom-made cDNA microarrays from a sequence-validated 13K cDNA library. Gene expression data from the commercial platforms showed good correlations across the experiments (r = 0.78–0.86), whereas the correlations between the custom-made and either of the two commercial platforms were lower (r = 0.62–0.76). Discrepant findings were due to clone errors on the custom-made microarrays, old annotations, or unknown causes. Even within platform, there can be several ways to analyze data that may influence the correlation between platforms. Our results indicate that combining data from different microarray platforms is not straightforward. Variability of the data represents a challenge for developing future diagnostic applications of microarrays.

AB - Many commercial and custom-made microarray formats are routinely used for large-scale gene expression surveys. Here, we sought to determine the level of concordance between microarray platforms by analyzing breast cancer cell lines with in situ synthesized oligonucleotide arrays (Affymetrix HG-U95v2), commercial cDNA microarrays (Agilent Human 1 cDNA), and custom-made cDNA microarrays from a sequence-validated 13K cDNA library. Gene expression data from the commercial platforms showed good correlations across the experiments (r = 0.78–0.86), whereas the correlations between the custom-made and either of the two commercial platforms were lower (r = 0.62–0.76). Discrepant findings were due to clone errors on the custom-made microarrays, old annotations, or unknown causes. Even within platform, there can be several ways to analyze data that may influence the correlation between platforms. Our results indicate that combining data from different microarray platforms is not straightforward. Variability of the data represents a challenge for developing future diagnostic applications of microarrays.

KW - cDNA microarrays

KW - Oligonucleotide microarrays

KW - Quality control

KW - Breast cancer

U2 - 10.1016/j.ygeno.2004.01.004

DO - 10.1016/j.ygeno.2004.01.004

M3 - Article

VL - 83

SP - 1164

EP - 1168

JO - Genomics

JF - Genomics

SN - 0888-7543

IS - 6

ER -

Järvinen A-K, Hautaniemi S, Edgren H, Auvinen P, Saarela J, Kallioniemi O et al. Are data from different gene expression microarray platforms comparable? Genomics. 2004;83(6):1164 - 1168. https://doi.org/10.1016/j.ygeno.2004.01.004